Special Feature
Demergers: The Cost of Pharma Divorce
Corporate spin-offs are on the rise across the pharmaceutical sector, but at what cost to shareholders? Brian McGilligan argues that in haste to obtain decree absolute, demerging businesses could be threatening their long-term viability ...Read more
Case Study: How a Biotech Saved $600,000 on a CRO Contract
Download a new case study to discover how a small biotech applied innovative eClinical software to:
* Save $600,000 on a single Phase II outsourcing contract
* Compress the contracting cycle-time from three months to two weeks
* Form a more constructive and collaborative working relationship with their CRO
 Download Now |
 |
Events
BIO 2012: The Case for Collaboration
Rodney King died on Sunday, but his famous question lives on: "Can we all get along?" At BIO 2012, the proposition seems to be: "Can we all just collaborate?" Ben Comer reports on some of the highlights of this year's event ...Read More
Technology
Meaningful Uses of HIT?
A diverse group of Health Information Technology (HIT) professionals — including physicians, academics, developers and entrepreneurs — gathered at Sudler & Hennessey's Health and Technology Summit in New York City to discuss the challenges related to health information technology implementation, and the ways to move forward ...Read More
Global
Who's the More Innovative: CROs or Pharma?
This was just one of the questions asked at PCMG's annual conference in Portugal last week. But perhaps the real question should have been, why is neither industry innovative enough? Julian Upton reports ...Read more
|
